NSE filing, NSE: BMLL. Summary written from the filing by ALFA Finder's alert engine.
Bio Medica Laboratories Ltd: key numbers
- Share price
- ₹154.90
- Market cap
- ₹194.8 Cr
- Revenue (annual)
- ₹43.09 Cr
- Net profit (annual)
- ₹11.89 Cr
- P/E (TTM)
- 16.4×Sector 46.1×
- Promoter holding
- 67.70%
- FII holding
- 4.78%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bio Medica Laboratories Ltd
All →Bio Medica Laboratories Other Announcement
Bio Medica Laboratories intimates non-applicability of its Q2 FY27 Corporate Governance Report under SEBI Reg 27(2). The SME-listed company claims exemption under Reg 15(2) of LODR.
Bio Medica Laboratories Annual General Meeting
Bio Medica Laboratories Ltd announced the outcome of its 11th Annual General Meeting, where shareholders approved financial statements, director re-appointment, auditor appointment, and FII investment limits.
Bio Medica Laboratories Annual General Meeting
Bio Medica Laboratories Limited has issued a notice for its 11th Annual General Meeting, scheduled for September 28, 2026, to conduct ordinary and special business.
Bio Medica Laboratories Management Change
Bio Medica Laboratories Limited has appointed M/s. Vishakha Agrawal & Associates as the Secretarial Auditor of the company effective September 2, 2026.
Bio Medica Laboratories Other Announcement
Bio Medica Laboratories Limited has appointed M/s. Vishakha Agrawal & Associates as the Secretarial Auditor of the Company, effective from September 02, 2026.
Bio Medica Laboratories Annual General Meeting
Bio Medica Laboratories shareholders approved multiple resolutions via postal ballot, including the disinvestment of subsidiary Vitamax Private Limited and related party transactions. The results are official.
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.